NCT06566079
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06566079
Title Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors InSilico Medicine Hong Kong Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE RECRUITING Denver Colorado 80218 United States Details
The University of Chicago Medical Center - Duchossois Center for Advanced Medicine RECRUITING Chicago Illinois 60637 United States Details
University Hospitals Cleveland Medical Center RECRUITING Cleveland Ohio 44106 United States Details
University of Pennsylvania - Abramson Cancer Center RECRUITING Philadelphia Pennsylvania 19104 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
NEXT Oncology - Austin RECRUITING Austin Texas 78758 United States Details
Henan Cancer Hospital RECRUITING Zhengzhou Henan China Details
Shanghai Pulmonary Hospital RECRUITING Shanghai Shanghai Municipality China Details
Cancer Hospital Chinese Academy of Medical Sciences RECRUITING Beijing China Details
Sun Yat-Sen University Cancer Center RECRUITING Guangzhou China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field